Charles Schwab’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Buy |
701,505
+16,609
| +2% | +$36.5K | ﹤0.01% | 2750 |
|
|
2025
Q1 | $794K | Buy |
684,896
+76,647
| +13% | +$88.9K | ﹤0.01% | 2922 |
|
|
2024
Q4 | $772K | Sell |
608,249
-9,031
| -1% | -$11.5K | ﹤0.01% | 2998 |
|
|
2024
Q3 | $2.1M | Sell |
617,280
-116,105
| -16% | -$396K | ﹤0.01% | 2696 |
|
|
2024
Q2 | $3.42M | Sell |
733,385
-122,710
| -14% | -$573K | ﹤0.01% | 2521 |
|
|
2024
Q1 | $6.35M | Buy |
856,095
+172,079
| +25% | +$1.28M | ﹤0.01% | 2198 |
|
|
2023
Q4 | $6.93M | Sell |
684,016
-4,948
| -0.7% | -$50.1K | ﹤0.01% | 2173 |
|
|
2023
Q3 | $5.37M | Buy |
688,964
+170,694
| +33% | +$1.33M | ﹤0.01% | 2218 |
|
|
2023
Q2 | $4.27M | Buy |
518,270
+4,920
| +1% | +$40.5K | ﹤0.01% | 2292 |
|
|
2023
Q1 | $3.72M | Buy |
513,350
+3,591
| +0.7% | +$26K | ﹤0.01% | 2330 |
|
|
2022
Q4 | $4.52M | Buy |
509,759
+10,303
| +2% | +$91.4K | ﹤0.01% | 2261 |
|
|
2022
Q3 | $6.11M | Buy |
499,456
+12,628
| +3% | +$155K | ﹤0.01% | 2111 |
|
|
2022
Q2 | $5.76M | Sell |
486,828
-10,746
| -2% | -$127K | ﹤0.01% | 2126 |
|
|
2022
Q1 | $9.46M | Buy |
497,574
+12,788
| +3% | +$243K | ﹤0.01% | 1988 |
|
|
2021
Q4 | $12.9M | Buy |
484,786
+9,699
| +2% | +$258K | ﹤0.01% | 1868 |
|
|
2021
Q3 | $19.5M | Sell |
475,087
-18,048
| -4% | -$741K | 0.01% | 1603 |
|
|
2021
Q2 | $27.9M | Buy |
493,135
+12,097
| +3% | +$685K | 0.01% | 1307 |
|
|
2021
Q1 | $20.2M | Buy |
481,038
+68,350
| +17% | +$2.87M | 0.01% | 1519 |
|
|
2020
Q4 | $28.9M | Buy |
412,688
+5,036
| +1% | +$353K | 0.01% | 1132 |
|
|
2020
Q3 | $11.4M | Buy |
407,652
+13,935
| +4% | +$391K | 0.01% | 1599 |
|
|
2020
Q2 | $11.6M | Buy |
393,717
+57,361
| +17% | +$1.7M | 0.01% | 1550 |
|
|
2020
Q1 | $6.67M | Buy |
336,356
+20,355
| +6% | +$404K | ﹤0.01% | 1687 |
|
|
2019
Q4 | $9.36M | Buy |
316,001
+16,818
| +6% | +$498K | 0.01% | 1696 |
|
|
2019
Q3 | $6.8M | Buy |
299,183
+30,646
| +11% | +$697K | ﹤0.01% | 1817 |
|
|
2019
Q2 | $6.64M | Buy |
268,537
+14,515
| +6% | +$359K | ﹤0.01% | 1833 |
|
|
2019
Q1 | $6.21M | Buy |
254,022
+11,392
| +5% | +$279K | ﹤0.01% | 1872 |
|
|
2018
Q4 | $5.52M | Sell |
242,630
-226
| -0.1% | -$5.14K | ﹤0.01% | 1856 |
|
|
2018
Q3 | $7.73M | Buy |
242,856
+28,891
| +14% | +$919K | 0.01% | 1798 |
|
|
2018
Q2 | $7.67M | Buy |
213,965
+29,981
| +16% | +$1.07M | 0.01% | 1767 |
|
|
2018
Q1 | $6.1M | Buy |
183,984
+46,209
| +34% | +$1.53M | ﹤0.01% | 1830 |
|
|
2017
Q4 | $4.23M | Buy |
137,775
+20,763
| +18% | +$638K | ﹤0.01% | 2007 |
|
|
2017
Q3 | $2.81M | Buy |
117,012
+18,366
| +19% | +$441K | ﹤0.01% | 2145 |
|
|
2017
Q2 | $1.66M | Buy |
98,646
+56,496
| +134% | +$948K | ﹤0.01% | 2285 |
|
|
2017
Q1 | $941K | Buy |
42,150
+3,249
| +8% | +$72.5K | ﹤0.01% | 2444 |
|
|
2016
Q4 | $632K | Buy |
38,901
+2,926
| +8% | +$47.5K | ﹤0.01% | 2577 |
|
|
2016
Q3 | $485K | Buy |
35,975
+16,610
| +86% | +$224K | ﹤0.01% | 2622 |
|
|
2016
Q2 | $473K | Buy |
19,365
+10,594
| +121% | +$259K | ﹤0.01% | 2605 |
|
|
2016
Q1 | $303K | Buy |
+8,771
| New | +$303K | ﹤0.01% | 2771 |
|